2021 Revenues ($USD) : $3,107,519,000
2021 R&D spend : $66,326,000
2021 Number of Employees : 13,000
Fiscal Year End : 3/31/2021
Key People : Dan Carestio, president and CEO.

About the company: Expect Steris to rise higher in its Big 100 ranking in 2022. The sterilization and surgical products company in June 2021 completed its acquisition of Cantel Medical, provider of infection prevention products and services to endoscopy, dental, dialysis and life sciences customers.  Walt Rosebrough left the corner office at Steris over the summer of 2021, with then-COO Dan Carestio promoted into the top spot. –CN